Detailed answers about DELTA PHARMACEUTICALS LIMITED, including incorporation, status, business activity, and accounts information.
When was DELTA PHARMACEUTICALS LIMITED founded?
DELTA PHARMACEUTICALS LIMITED was officially incorporated on 13 April 2026 and is registered under company number 17154876. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DELTA PHARMACEUTICALS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DELTA PHARMACEUTICALS LIMITED?
DELTA PHARMACEUTICALS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DELTA PHARMACEUTICALS LIMITED do?
DELTA PHARMACEUTICALS LIMITED operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 47730 - Dispensing chemist in specialised stores, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is DELTA PHARMACEUTICALS LIMITED's registered address?
The registered office address of DELTA PHARMACEUTICALS LIMITED is 9 Church Street, Wednesfield, Wolverhampton, England, WV11 1SR. This is the official address filed with Companies House for legal and statutory correspondence.
Is DELTA PHARMACEUTICALS LIMITED financially stable?
Financial accounts for DELTA PHARMACEUTICALS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.